denkapparat Operations GmbH Takes Position in Centene Co. (NYSE:CNC)

denkapparat Operations GmbH bought a new stake in Centene Co. (NYSE:CNCFree Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 6,396 shares of the company’s stock, valued at approximately $387,000.

Several other hedge funds also recently made changes to their positions in the business. Capital Advisors Ltd. LLC increased its position in shares of Centene by 75.3% in the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock valued at $25,000 after acquiring an additional 177 shares during the last quarter. Rialto Wealth Management LLC bought a new position in shares of Centene during the 4th quarter worth approximately $30,000. OFI Invest Asset Management bought a new stake in Centene in the 4th quarter valued at $33,000. SRS Capital Advisors Inc. increased its holdings in shares of Centene by 73.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 631 shares of the company’s stock valued at $38,000 after purchasing an additional 267 shares during the last quarter. Finally, Riverview Trust Co lifted its stake in shares of Centene by 172.7% during the 4th quarter. Riverview Trust Co now owns 758 shares of the company’s stock worth $46,000 after buying an additional 480 shares during the last quarter. 93.63% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have weighed in on CNC shares. Wells Fargo & Company lowered their price target on shares of Centene from $76.00 to $72.00 and set an “overweight” rating on the stock in a report on Friday, February 14th. Robert W. Baird increased their price objective on Centene from $66.00 to $71.00 in a research report on Tuesday, February 4th. StockNews.com lowered shares of Centene from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 6th. JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a $75.00 target price (down from $80.00) on shares of Centene in a report on Tuesday, December 17th. Finally, Barclays increased their target price on Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a report on Friday, December 13th. One analyst has rated the stock with a sell rating, five have issued a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $79.92.

View Our Latest Stock Analysis on Centene

Centene Stock Down 0.5 %

NYSE:CNC opened at $60.23 on Friday. The firm’s 50 day simple moving average is $59.98 and its 200 day simple moving average is $62.86. The company has a market cap of $29.88 billion, a PE ratio of 9.65, a P/E/G ratio of 0.80 and a beta of 0.40. Centene Co. has a one year low of $55.03 and a one year high of $80.59. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10.

Centene (NYSE:CNCGet Free Report) last posted its quarterly earnings data on Tuesday, February 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.31. Centene had a return on equity of 13.85% and a net margin of 2.03%. The business had revenue of $40.81 billion during the quarter, compared to the consensus estimate of $38.78 billion. During the same period in the prior year, the business posted $0.45 earnings per share. Centene’s quarterly revenue was up 3.4% on a year-over-year basis. On average, research analysts anticipate that Centene Co. will post 6.86 earnings per share for the current year.

About Centene

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Further Reading

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.